{
  "ticker": "DVL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969829",
  "id": "02969829",
  "pages": 25,
  "price_sensitive": false,
  "date": "20250716",
  "time": "1402",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lvh0nh2r28t2.pdf",
  "summary": "### **Material Information Summary \u2013 dorsaVi Ltd EGM Announcement**  \n\n#### **Capital Raising & Securities Issuance Approvals**  \n1. **Placement Ratification & Approval**  \n   - **Ratification of Tranche 1 Placement Shares**:  \n     - **105M shares** issued on 27 June 2025 at **$0.013/share** (Listing Rule 7.1 \u2013 Resolution 1).  \n     - **70M shares** issued on 4 July 2025 at **$0.013/share** (Listing Rule 7.1A \u2013 Resolution 2).  \n   - **Tranche 2 Placement Approval**: **12.5M shares** at **$0.013/share** (Resolution 3).  \n   - **Total Placement Proceeds**: **~$2.44M** (before costs), allocated to RRAM integration and working capital.  \n\n2. **Advisory Fee Securities Issuance**  \n   - **62 Capital Options**: **20M unlisted options** (exercise price **$0.02**, 3-year term) for lead manager services (Resolution 4).  \n   - **Clayton Capital Shares**: **60M shares** issued for advisory services (Resolution 5).  \n\n3. **Performance Rights Issuance**  \n   - **62 Capital**: **40M performance rights** tied to share price hurdles ($0.020\u2013$0.040 VWAP over 15 days) (Resolution 6).  \n   - **Directors**:  \n     - **Gernot Abl**: **10M performance rights** ($0.020\u2013$0.030 VWAP) (Resolution 7).  \n     - **Leigh Travers**: **10M performance rights** ($0.020\u2013$0.030 VWAP) (Resolution 8).  \n\n4. **Director Shares in Lieu of Accrued Leave**  \n   - **Dr. Andrew Ronchi**: **2.7M shares** at **$0.028/share** (deemed price) (Resolution 9).  \n\n#### **Key Timetable**  \n- **Meeting Date**: **15 August 2025** (virtual, 11:00 AEST).  \n- **Proxy Deadline**: **13 August 2025, 11:00 AEST**.  \n\n#### **Voting Exclusions**  \nResolutions 1\u20139 exclude votes from related parties/beneficiaries (e.g., placement participants, 62 Capital, Clayton Capital, directors).  \n\n#### **Board Recommendation**  \nUnanimous support for all resolutions.  \n\n**Notes**:  \n- No trading halt or liquidity impact disclosed.  \n- All issuances subject to shareholder approval at EGM.  \n\n*Summary tailored for capital markets focus; excludes procedural/legal boilerplate.*",
  "usage": {
    "prompt_tokens": 18814,
    "completion_tokens": 585,
    "total_tokens": 19399,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T04:10:53.976946"
}